Trial Profile
Randomized,Double-blind,Placebo-controlled,Dose-escalating Phase I,Healthy Subjects Study of JY09,a Recombinant GLP-1 Receptor Agonist
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs JY 09 (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Beijing Dongfang Biotech
- 29 Nov 2016 New trial record